Skip to main content
Market intelligence
FEMYSector not reported

Femasys Inc insider activity

In the last 90 days, 5 corporate insiders purchased $134,000 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
4
90-day purchase value
$134,000
Corporate buyers
5
Latest transaction
Aug 7, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 7, 2026Jeffrey Gerald MifekChief Clinical-Medical AffairsOpen Market Purchase3,125$3.20$10,000
Aug 7, 2026Jeremy Alexander SiposChief Technology OfficerOpen Market Purchase3,125$3.20$10,000
Aug 7, 2026John Charles CanningChief Operating OfficerOpen Market Purchase4,375$3.20$14,000